Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Dropped 22.3% in First Half of 2022

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 2.1 billion yuan in the first half of 2022, down 22.3% year-on-year.

Meanwhile, the company posted 10.2 billion yuan in revenue, down 23.1% year-on-year.

At the end of the reporting period, it had 40.7 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 10.1%.